• 1

    Hugo Boss

    Fashion retailer
    Cost
    £155.8m
    Value
    £345.6m
    % of total assets
    27.9%
    Date of acquisition
    May 07

    Fund: Permira IV

    Hugo Boss operates in the fashion and luxury goods market. It is the global leader in the formal menswear fashion market with a presence of over 6,800 points of sale across 129 countries. The valuation basis is quoted.

    Visit the company's website

  • 2

    Arysta LifeScience

    Agrochemicals
    Cost
    £160.1m
    Value
    £207.4m
    % of total assets
    16.7%
    Date of acquisition
    Feb 08

    Fund: Permira IV

    Arysta LifeScience is one of the world’s largest privately-held agrochemical businesses, specialising in crop protection including herbicides, insecticides and fungicides, as well as a number of products for the healthcare and veterinary medicine markets. Headquartered in Tokyo, the company markets a portfolio of more than 150 products in over 125 countries. The valuation basis is earnings.

    Visit the company's website

  • 3 Freescale

    Freescale

    Embedded semiconductors
    Cost
    £145.1m
    Value
    £82.5m
    % of total assets
    6.7%
    Date of acquisition
    Nov 06

    Fund: Permira IV

    Freescale is a global leader in embedded processing solutions for the automotive, consumer, industrial and networking markets. The company has a heritage of innovation and product leadership spanning more than 50 years and has an extensive intellectual property portfolio, including approximately 6,000 patent families, and serves more than 18,000 customers with leading products and solutions. The valuation basis is quoted.

    Visit the company's website

  • 4

    iglo Group

    Frozen food
    Cost
    £25.3m
    Value
    £53.0m
    % of total assets
    4.3%
    Date of acquisition
    Nov 06

    Fund: Permira Europe III

    The iglo Group is a branded European frozen food company that produces fish, vegetables and poultry, including a number of iconic products such as Fish Fingers, Schlemmer Filets and Sofficini. The Group operates under three brands: Birds Eye (UK and Ireland), iglo (Germany, Austria, Belgium, The Netherlands and other countries) and Findus (Italy). The valuation basis is earnings.

    Visit the company's website

  • 5

    The Hillman Group

    Hardware retailer
    Cost
    £23.0m
    Value
    £23.0m
    % of total assets
    1.9%
    Date of acquisition
    Jun 14

    Fund: CCMP III and co-investment

    The Hillman Group is a leader in the hardware and home improvement industry distributing over 130,000 stock keeping units (SKUs) in categories including fasteners, key duplication systems, letters, numbers and signs, engraved tags, builder’s hardware, and the recently added nail, deck and drywall category. The company provides inventory management and in-store merchandising services to its retail customers for managing these SKU-intensive, complex home improvement categories. The valuation basis is cost.

    Visit the company's website

  • 6 New Look

    New Look

    Fashion retailer
    Cost
    £0.4m
    Value
    £18.5m
    % of total assets
    1.5%
    Date of acquisition
    Apr 04

    Fund: Permira Europe II

    New Look is a leading European high-street apparel retailer with over 1,100 stores across the globe in 22 countries. It has circa 580 New Look stores in the UK and a growing presence in Europe (circa 90 stores). It also has a growing franchise operation across the Middle East, CEE and Asia. The group also operates circa 280 stores across France and Belgium which trade under the Mim brand, including a growing affiliate business in France. The valuation basis is earnings.

    Visit the company's website

  • 7

    Legico

    Finance
    Cost
    £10.6m
    Value
    £16.7m
    % of total assets
    1.3%
    Date of acquisition
    Jan 08

    Fund: Permira IV

    Legico seeks to invest in senior and subordinated LBO debt. Legico’s aim is to acquire high quality debt assets with attractive yields by investing in senior, mezzanine and PIK opportunities in both the primary and secondary markets. Legico is advised by the Permira Debt Managers team. The valuation basis is mark-to-market.

  • 8

    Acromas (AA Saga)

    Motoring, travel, media, finance
    Cost
    £3.7m
    Value
    £15.7m
    % of total assets
    1.3%
    Date of acquisition
    Sep 04

    Fund: Permira Europe III

    Acromas was the holding company for The AA and Saga, two of the UK’s most iconic brand names. Following the full realisation of The AA through an IPO in H1 2014, the remaining investment represents Acromas’ holding of Saga quoted shares. Saga provides financial services to people aged over 50 in the UK, as well as personal financial products, travel and domiciliary care. The valuation basis is quoted.

    Visit the company's website

  • 9

    All3Media

    Television
    Cost
    £5.3m
    Value
    £8.2m
    % of total assets
    0.7%
    Date of acquisition
    Sep 06

    Fund: Permira Europe III

    All3Media is the UK’s largest group of independent TV production companies. It comprises over 15 companies and 28 creative centres based in the UK, the US, Germany, the Netherlands and Australasia. It produces over 500 programmes annually with particular strengths in soap, drama, factual entertainment, and scripted reality genres. Shows include Midsomer Murders, Hollyoaks, Shameless, Undercover Boss, The Cube, Kitchen Nightmares, Skins, Peep Show and The Only Way is Essex. The sale of All3Media will complete in the second half. The valuation basis is expected sales proceeds.

    Visit the company's website

  • 10

    AMCo

    Pharmaceuticals
    Cost
    £5.3m
    Value
    £8.0m*
    % of total assets
    0.6%
    Date of acquisition
    Aug/Oct 12

    Fund: Fifth Cinven Fund

    Amdipharm Mercury (AMCo) is an international specialty pharmaceuticals company delivering high quality medicines with a customer focus in 112 territories. AMCo is the result of the merger of Amdipharm and the Mercury Pharma Group to create a single, consolidated, international specialty pharmaceuticals company. The valuation basis is earnings.

    Visit the company's website

    * The Fifth Cinven Fund portfolio valuations are based on 31 March 2014 fund value, updated for any cash flow and foreign exchange movements